<Version>
  <xmlSource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Quality Measures Clearinghouse (NQMC).</xmlSource>
  <Section SecID="560" OrdBy="10" Name="General">
    <Field FieldID="11" OrdBy="20" ID="561" Name="Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Diagnosis and treatment of osteoporosis: percentage of patients diagnosed with osteoporosis who are on pharmacologic therapy.&lt;/div&gt;" />
    </Field>
    <Field FieldID="1" OrdBy="30" ID="562" Name="Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Florence R, Allen S, Benedict L, Compo R, Jensen A, Kalogeropoulou D, Kearns A, Larson S, Mallen E, O'Day K, Peltier A, Webb B. Diagnosis and treatment of osteoporosis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2013 Jul. 87 p.  [210 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
  </Section>
  <Section SecID="563" OrdBy="40" Name="Measure Domain">
    <Field FieldID="3025" OrdBy="50" ID="564" Name="Primary Measure Domain" Type="picklist-one">
      <FieldValue Value="Clinical Quality Measures: Process" />
    </Field>
    <Field FieldID="3026" OrdBy="60" ID="565" Name="Secondary Measure Domain" Type="picklist-one">
      <FieldValue Value="Does not apply to this measure" />
    </Field>
  </Section>
  <Section SecID="566" OrdBy="70" Name="Brief Abstract">
    <Field FieldID="34" OrdBy="80" ID="567" Name="Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This measure is used to assess the percentage of patients age 50 years and older diagnosed with osteoporosis who are on pharmacologic therapy.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="21" OrdBy="90" ID="568" Name="Rationale" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The priority aim addressed by this measure is to increase the percentage of female and male patients age 50 years and older and diagnosed with osteoporosis who receive treatment for osteoporosis.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Osteoporosis is a generalized skeletal disorder characterized by compromised bone strength and deterioration of bone quality, often leading to fragility (low trauma) fractures. The World Health Organization (WHO) defines osteoporosis as a bone density of 2.5 standard deviations or more below a reference group of young Caucasian females (WHO, 2004). A low bone mass is frequently found, but not required, for the diagnosis. (A fragility fracture, regardless of the bone mass, necessitates the diagnosis.) Osteoporosis is by far the most common bone disease (WHO, 2004). Osteoporosis can be a primary disorder or can be caused by a host of other factors (e.g., diseases, lifestyle, medications, etc.). The impact of this disorder is massive in terms of cost, morbidity and mortality. An estimated 1.5 million individuals suffer a fragility fracture annually (Riggs et al., 1998). An estimated 40% of women and 25% to 33% of men during their lifetime will suffer a hip, spine or wrist fracture in their lifetime (Binkley et al., 2006). Projections indicate a two- to threefold increase in osteoporosis by 2040 (U.S. Preventive Services Task Force, 2012).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The major challenges facing this field currently include low rates of initial screening with dual-energy X-ray absorptiometry (DXA), lack of initial treatment in cases with a high fracture risk, and poor adherence with prescribed treatment.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Several effective bone agents have been developed since the advent of bisphosphonates in 1994. Most of these are &quot;antiresorptive&quot; agents, and one is an anabolic (bone forming) drug. These medications generally decrease fracture risk by 50% in patients who adhere to the medication treatment. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;Women with prior fracture and low bone density are the most responsive to antiresorptive therapy, and pharmaceutical trials suggest that women with prior fracture can reduce their risk for subsequent fractures by 30% to 50%. This has been shown for U.S. Federal Drug Administration (FDA)-approved osteoporosis therapies. The largest therapy-induced bone mineral density (BMD) increase is observed in patients with the lowest BMD and vertebral fractures, the population at highest risk (Ettinger et al., 1999; Hochberg et al., 1999).&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3500" OrdBy="100" ID="569" Name="Evidence for Rationale" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Binkley N, Bilezikian JP, Kendler DL, Leib ES, Lewiecki EM, Petak SM, International Society for Clinical Densitometry. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom. 2006 Jan-Mar;9(1):4-14. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16731426&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, GlÃ¼er CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999 Aug 18;282(7):637-45. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10517716&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Florence R, Allen S, Benedict L, Compo R, Jensen A, Kalogeropoulou D, Kearns A, Larson S, Mallen E, O'Day K, Peltier A, Webb B. Diagnosis and treatment of osteoporosis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2013 Jul. 87 p.  [210 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D. Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum. 1999 Jun;42(6):1246-54. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10366118&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Riggs BL, O'Fallon WM, Muhs J, O'Connor MK, Kumar R, Melton LJ. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res. 1998 Feb;13(2):168-74. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9495509&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;World Health Organization (WHO). WHO scientific group on the assessment of osteoporosis at primary health care level. Summary Meeting Report. Brussels (Belgium): World Health Organization (WHO); 2004 May 5-7. 17 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="3022" OrdBy="110" ID="570" Name="Primary Health Components" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Osteoporosis; pharmacologic therapy&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="23" OrdBy="120" ID="571" Name="Denominator Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Number of patients age 50 years and older with a diagnosis of osteoporosis&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="24" OrdBy="130" ID="572" Name="Numerator Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Number of patients who are on pharmacologic therapy&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="573" OrdBy="140" Name="Evidence Supporting the Measure">
    <Field FieldID="3027" OrdBy="150" ID="574" Name="Type of Evidence Supporting the Criterion of Quality for the Measure" Type="picklist-choice">
      <FieldValue Value="A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence" />
    </Field>
    <Field FieldID="3501" OrdBy="160" ID="575" Name="Additional Information Supporting Need for the Measure" Type="text">
      <FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Of the types of fractures, the most devastating effects are from hip fractures. Most of these occur after a fall, which are more frequent with aging. The one-year mortality rate of a hip fracture is approximately 28% in women and 35% in men (U.S. Department of Health and Human Services, 2004). Some, but not all, of these deaths would be avoided with preventive interventions. Twenty-five percent of these patients will become disabled, and many will require long-term nursing home placement (Ray, 1997). Given the aging population, the frequency, cost and burden of fractures will continue to increase. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Annual direct care expenditures for osteoporotic fractures ranged from $12.2 billion to $17.9 billion in 1999. This constitutes 7% of total health care costs for women over the age of 45 (Hoerger, 1999). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It is estimated that 50% of women over age 50 will develop a fracture in their remaining lifetime and the annualized risk increases with age. Twenty-five percent of women over age 50 will experience an osteoporotic vertebral fracture, so that by age 75 more than one in three women has sustained at least one vertebral fracture. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" />
    </Field>
    <Field FieldID="3502" OrdBy="170" ID="576" Name="Evidence for Additional Information Supporting Need for the Measure" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Florence R, Allen S, Benedict L, Compo R, Jensen A, Kalogeropoulou D, Kearns A, Larson S, Mallen E, O'Day K, Peltier A, Webb B. Diagnosis and treatment of osteoporosis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2013 Jul. 87 p.  [210 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;U.S. Department of Health and Human Services (DHHS), Office of the Surgeon General. Bone health and osteoporosis: a report of the Surgeon General. Rockville (MD): U.S. Department of Health and Human Services (DHHS); 2004. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="3072" OrdBy="180" ID="577" Name="Extent of Measure Testing" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="580" OrdBy="210" Name="State of Use of the Measure">
    <Field FieldID="3029" OrdBy="220" ID="581" Name="State of Use" Type="picklist-one">
      <FieldValue Value="Current routine use" />
    </Field>
    <Field FieldID="3030" OrdBy="230" ID="582" Name="Current Use" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
  </Section>
  <Section SecID="583" OrdBy="240" Name="Application of the Measure in its Current Use">
    <Field FieldID="3031" OrdBy="250" ID="584" Name="Measurement Setting" Type="picklist-choice">
      <FieldValue Value="Ambulatory/Office-based Care" />
    </Field>
    <Field FieldID="3032" OrdBy="260" ID="585" Name="Professionals Involved in Delivery of Health Services" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
    <Field FieldID="3033" OrdBy="270" ID="586" Name="Least Aggregated Level of Services Delivery Addressed" Type="picklist-one">
      <FieldValue Value="Clinical Practice or Public Health Sites" />
    </Field>
    <Field FieldID="3505" OrdBy="280" ID="587" Name="Statement of Acceptable Minimum Sample Size" Type="picklist-one">
      <FieldValue Value="Unspecified" />
    </Field>
    <Field FieldID="41" OrdBy="290" ID="588" Name="Target Population Age" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Age greater than or equal to&amp;nbsp;50 years&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="42" OrdBy="300" ID="589" Name="Target Population Gender" Type="picklist-one">
      <FieldValue Value="Either male or female" />
    </Field>
  </Section>
  <Section SecID="660" OrdBy="310" Name="National Strategy for Quality Improvement in Health Care">
    <Field FieldID="3522" OrdBy="320" ID="661" Name="National Quality Strategy Aim" Type="text">
      <FieldValue Value="&lt;ul&gt;&lt;li&gt;Better Care&lt;/li&gt;&lt;/ul&gt;" />
    </Field>
    <Field FieldID="3525" OrdBy="330" ID="662" Name="National Quality Strategy Priority" Type="text">
      <FieldValue Value="&lt;ul&gt;&lt;li&gt;Prevention and Treatment of Leading Causes of Mortality&lt;/li&gt;&lt;/ul&gt;" />
    </Field>
  </Section>
  <Section SecID="590" OrdBy="340" Name="Institute of Medicine (IOM) National Health Care Quality Report Categories">
    <Field FieldID="3163" OrdBy="350" ID="591" Name="IOM Care Need" Type="picklist-choice">
      <FieldValue Value="Living with Illness" />
    </Field>
    <Field FieldID="3164" OrdBy="360" ID="592" Name="IOM Domain" Type="picklist-choice">
      <FieldValue Value="Effectiveness" />
    </Field>
  </Section>
  <Section SecID="593" OrdBy="370" Name="Data Collection for the Measure">
    <Field FieldID="3506" OrdBy="380" ID="594" Name="Case Finding Period" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The time frame pertaining to data collection is monthly, quarterly, semi-annually or annually.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3054" OrdBy="390" ID="595" Name="Denominator Sampling Frame" Type="picklist-one">
      <FieldValue Value="Patients associated with provider" />
    </Field>
    <Field FieldID="3057" OrdBy="400" ID="598" Name="Denominator (Index) Event or Characteristic" Type="picklist-choice">
      <FieldValue Value="Clinical Condition" />
      <FieldValue Value="Patient/Individual (Consumer) Characteristic" />
    </Field>
    <Field FieldID="3058" OrdBy="410" ID="599" Name="Denominator Time Window" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
    <Field FieldID="55" OrdBy="420" ID="596" Name="Denominator Inclusions/Exclusions" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Number of patients age 50 years and older with a diagnosis of osteoporosis&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Unspecified &lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3507" OrdBy="430" ID="597" Name="Exclusions/Exceptions" Type="picklist-choice-4">
      <FieldValue Value="not defined yet" />
    </Field>
    <Field FieldID="59" OrdBy="440" ID="600" Name="Numerator Inclusions/Exclusions" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Number of patients who are on pharmacologic therapy&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions &lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Unspecified &lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3061" OrdBy="450" ID="601" Name="Numerator Search Strategy" Type="picklist-one">
      <FieldValue Value="Fixed time period or point in time" />
    </Field>
    <Field FieldID="3062" OrdBy="460" ID="602" Name="Data Source" Type="picklist-many">
      <FieldValue Value="Electronic health/medical record" />
    </Field>
    <Field FieldID="3065" OrdBy="470" ID="603" Name="Type of Health State" Type="picklist-one">
      <FieldValue Value="Does not apply to this measure" />
    </Field>
    <Field FieldID="3066" OrdBy="480" ID="604" Name="Instruments Used and/or Associated with the Measure" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="605" OrdBy="490" Name="Computation of the Measure">
    <Field FieldID="3508" OrdBy="500" ID="606" Name="Measure Specifies Disaggregation" Type="picklist-one">
      <FieldValue Value="Does not apply to this measure" />
    </Field>
    <Field FieldID="3067" OrdBy="520" ID="608" Name="Scoring" Type="picklist-many">
      <FieldValue Value="Rate/Proportion" />
    </Field>
    <Field FieldID="3068" OrdBy="530" ID="609" Name="Interpretation of Score" Type="picklist-one">
      <FieldValue Value="Desired value is a higher score" />
    </Field>
    <Field FieldID="3090" OrdBy="540" ID="610" Name="Allowance for Patient or Population Factors" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
    <Field FieldID="3070" OrdBy="560" ID="612" Name="Standard of Comparison" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
  </Section>
  <Section SecID="615" OrdBy="590" Name="Identifying Information">
    <Field FieldID="73" OrdBy="600" ID="616" Name="Original Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Percentage of patients diagnosed with osteoporosis who are on pharmacologic therapy.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="74" OrdBy="610" ID="617" Name="Measure Collection Name" Type="text">
      <FieldValue Value="Diagnosis and Treatment of Osteoporosis" />
    </Field>
    <Field FieldID="16" OrdBy="650" ID="621" Name="Submitter" Type="orglist">
      <FieldValue Value="Institute for Clinical Systems Improvement - Nonprofit Organization" />
    </Field>
    <Field FieldID="17" OrdBy="660" ID="622" Name="Developer" Type="orglist-p">
      <FieldValue Value="Institute for Clinical Systems Improvement - Nonprofit Organization" />
    </Field>
    <Field FieldID="79" OrdBy="670" ID="623" Name="Funding Source(s)" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The Institute for Clinical Systems Improvement's (ICSI's) work is funded by the annual dues of the member medical groups and five sponsoring health plans in Minnesota and Wisconsin.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="80" OrdBy="680" ID="624" Name="Composition of the Group that Developed the Measure" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Work Group Members&lt;/em&gt;: Robert Florence, MD, FACP, CDD (&lt;em&gt;Work Group Leader&lt;/em&gt;) (Allina Medical Clinic) (Internal Medicine); Luke Benedict, MD (Allina Medical Clinic) (Endocrinology); Sarah Larson (Allina Medical Clinic) (Radiology); Kathryn O'Day, MD (Allina Medical Clinic) (Endocrinology); Renee Compo, RN, CNP (HealthPartners Medical Group and Regions Hospital) (Nursing); Amanda Jensen, RTR (HealthPartners Medical Group and Regions Hospital) (Radiology); Dionysia Kalogeropoulou, MD (HealthPartners Medical Group and Regions Hospital) (Endocrinology); Amber Peltier, PharmD (HealthPartners Medical Group and Regions Hospital) (Pharmacy); Ann Kearns, MD, PhD (Mayo Clinic) (Endocrinology); Sharon Allen, MD (University of Minnesota Physicians) (Family Medicine); Emily Mallen, MBA (Institute for Clinical Systems Improvement [ICSI]) (Project Manager); Beth Webb, RN, BA (ICSI) (Project Manager) &lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="81" OrdBy="690" ID="625" Name="Financial Disclosures/Other Potential Conflicts of Interest" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The Institute for Clinical Systems Improvement (ICSI) has long had a policy of transparency in declaring potential conflicting and competing interests of all individuals who participate in the development, revision and approval of ICSI guidelines and protocols. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;In 2010, the ICSI Conflict of Interest Review Committee was established by the Board of Directors to review all disclosures and make recommendations to the board when steps should be taken to mitigate potential conflicts of interest, including recommendations regarding removal of work group members. This committee has adopted the Institute of Medicine Conflict of Interest standards as outlined in the report Clinical Practice Guidelines We Can Trust (2011). &lt;/p&gt;&#xD;&#xA;&lt;p&gt;Where there are work group members with identified potential conflicts, these are disclosed and discussed at the initial work group meeting. These members are expected to recuse themselves from related discussions or authorship of related recommendations, as directed by the Conflict of Interest committee or requested by the work group.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The complete ICSI policy regarding Conflicts of Interest is available at the &lt;a href=&quot;https://www.icsi.org/_asset/fwsfmi/coi_policyletter.pdf&quot; title=&quot;ICSI Web site&quot;&gt;ICSI Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Disclosure of Potential Conflicts of Interest&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Sharon Allen, MD (Work Group Member)&lt;/strong&gt; &lt;br /&gt;&#xD;&#xA;Family Medicine, University of Minnesota Physicians &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: None &lt;br /&gt;&#xD;&#xA;Research Grants: Programmatic support from the National Institute on Drug Abuse (NIDA) &amp;ndash; Nicotine dependence in pregnancy and post partum. Money to institution, none to individual member. &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: None &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Luke Benedict, MD (Work Group Member) &lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Endocrinology, Allina Medical Clinics &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: None &lt;br /&gt;&#xD;&#xA;Research Grants: None &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: Paid participant of a study evaluating efficacy of a blood glucose meter in identifying trends in blood sugars &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Renee B. Compo, RN, CNP (Work Group Member) &lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Women's Health, HealthPartners Medical Group and Regions Hospital &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: None &lt;br /&gt;&#xD;&#xA;Research Grants: None &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: None &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Robert Florence, MD, FACP, CCD (Work Group Leader) &lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Internal Medicine, Allina Medical Clinics &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: None &lt;br /&gt;&#xD;&#xA;Research Grants: None &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: None &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Amanda Jensen, RTR (Work Group Member)&lt;/strong&gt; &lt;br /&gt;&#xD;&#xA;HealthPartners Medical Group and Regions Hospital &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: None &lt;br /&gt;&#xD;&#xA;Research Grants: None &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: None &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Dionysia Kalogeropoulou, MD (Work Group Member)&lt;/strong&gt; &lt;br /&gt;&#xD;&#xA;HealthPartners Medical Group and Regions Hospital &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: ICSI Diabetes Guideline &lt;br /&gt;&#xD;&#xA;Research Grants: None &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: None &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Ann Kearns, MD, PhD (Work Group Member)&lt;/strong&gt; &lt;br /&gt;&#xD;&#xA;Endocrinology, Mayo Clinic &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: None &lt;br /&gt;&#xD;&#xA;Research Grants: None &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: None &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Sarah Larsen (Work Group Member)&lt;/strong&gt; &lt;br /&gt;&#xD;&#xA;Allina Medical Clinics &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: None &lt;br /&gt;&#xD;&#xA;Research Grants: None &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: None &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Kathryn O'Day, MD (Work Group Member) &lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Endocrinology, Allina Medical Clinics &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: None&lt;br /&gt;&#xD;&#xA;Research Grants: Fairview Physicians Associates &amp;ndash; None &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: None &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Amber Peltier, PharmD (Work Group Member)&lt;/strong&gt; &lt;br /&gt;&#xD;&#xA;Pharmacy, HealthPartners Medical Group &lt;br /&gt;&#xD;&#xA;National, Regional, Local Committee Affiliations: None &lt;br /&gt;&#xD;&#xA;Guideline-Related Activities: None &lt;br /&gt;&#xD;&#xA;Research Grants: Thrasher Research Foundation &amp;ndash; None &lt;br /&gt;&#xD;&#xA;Financial/Non-financial Conflicts of Interest: None&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="19" OrdBy="730" ID="629" Name="Adaptation" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This measure was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3086" OrdBy="740" ID="630" Name="Date of Most Current Version in NQMC" Type="date">
      <FieldValue Value="2013 Jul" />
    </Field>
    <Field FieldID="3511" OrdBy="750" ID="631" Name="Measure Maintenance" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Scientific documents are revised every 12 to 24 months as indicated by changes in clinical practice and literature.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3512" OrdBy="760" ID="632" Name="Date of Next Anticipated Revision" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The next scheduled revision will occur within 24 months.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="20" OrdBy="770" ID="633" Name="Measure Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the measure.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The measure developer reaffirmed the currency of this measure in January 2016.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="14" OrdBy="780" ID="634" Name="Measure Availability" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Source available for purchase from the &lt;a href=&quot;https://www.icsi.org/guidelines__more/purchase_guidelines/&quot; title=&quot;ICSI Web site&quot;&gt;Institute for Clinical Systems Improvement (ICSI) Web site&lt;/a&gt;. Also available to ICSI members for free at the &lt;a href=&quot;https://www.icsi.org/guidelines__more/member_access/&quot; title=&quot;ICSI Web site&quot;&gt;ICSI Web site&lt;/a&gt; and to Minnesota health care organizations free by request at the &lt;a href=&quot;https://www.icsi.org/guidelines__more/minnesota_nonmember_access/&quot; title=&quot;ICSI Web site&quot;&gt;ICSI Web site&lt;/a&gt;. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;For more information, contact ICSI at 8009 34th Avenue South, Suite 1200, Bloomington, MN 55425; Phone: 952-814-7060; Fax: 952-858-9675; Web site: &lt;a href=&quot;http://www.icsi.org&quot; title=&quot;ICSI Web site&quot;&gt;www.icsi.org&lt;/a&gt;; E-mail: &lt;a href=&quot;mailto:icsi.info@icsi.org&quot;&gt;icsi.info@icsi.org&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="87" OrdBy="800" ID="636" Name="NQMC Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NQMC summary was completed by ECRI Institute on April 9, 2014.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The information was reaffirmed by the measure developer on January 13, 2016.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="88" OrdBy="810" ID="637" Name="Copyright Statement" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NQMC summary (abstracted Institute for Clinical Systems Improvement [ICSI] Measure) is based on the original measure, which is subject to the measure developer's copyright restrictions. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;The abstracted ICSI Measures contained in this Web site may be downloaded by any individual or organization. If the abstracted ICSI Measures are downloaded by an individual, the individual may not distribute copies to third parties. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;If the abstracted ICSI Measures are downloaded by an organization, copies may be distributed to the organization's employees but may not be distributed outside of the organization without the prior written consent of the Institute for Clinical Systems Improvement, Inc. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;All other copyright rights in the abstracted ICSI Measures are reserved by the Institute for Clinical Systems Improvement, Inc. The Institute for Clinical Systems Improvement, Inc. assumes no liability for any adaptations or revisions or modifications made to the abstracts of the ICSI Measures. &lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="641" OrdBy="850" Name="Production">
    <Field FieldID="1" OrdBy="1366" ID="562" Name="Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Florence R, Allen S, Benedict L, Compo R, Jensen A, Kalogeropoulou D, Kearns A, Larson S, Mallen E, O'Day K, Peltier A, Webb B. Diagnosis and treatment of osteoporosis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2013 Jul. 87 p.  [210 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
  </Section>
  <Section SecID="99999" OrdBy="99999" Name="Disclaimer">
    <Field FieldID="99999" OrdBy="99999" ID="99999" Name="NQMC Disclaimer" Type="text">
      <FieldValue Value="&lt;p&gt;The National Quality Measures Clearinghouseâ¢ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the &lt;a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;&gt;NQMC Inclusion Criteria&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding measure content are directed to contact the measure developer.&lt;/p&gt;" />
    </Field>
  </Section>
</Version>